SLC43A2-SMYD4 Fusion FISH Probe
The SLC43A2-SMYD4 Fusion FISH Probe is used to confirm a fusion of the SLC43A2 and SMYD4 genes. The fusion of the SLC43A2 and SMYD4 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC43A2-SMYD4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC43A2-SMYD4-20-AQAQ | 20 (40 μL) | 200 μL |
|
SMYD4 Gene Summary
The SET And MYND Domain Containing 4 (SMYD4) gene is located on chr17 :1682828-1733175 at 17p13.3.
Gene Name: SET And MYND Domain Containing 4
Chromosome: CHR17: 1682828 -1733175
Locus: 17p13.3
SLC43A2 Gene Summary
This gene encodes a member of the L-amino acid transporter-3 or SLC43 family of transporters. The encoded protein mediates sodium-, chloride-, and pH-independent transport of L-isomers of neutral amino acids, including leucine, phenylalanine, valine and methionine. This protein may contribute to the transfer of amino acids across the placental membrane to the fetus. [provided by RefSeq, Mar 2016]
Gene Name: Solute Carrier Family 43 Member 2
Chromosome: CHR17: 1477695 -1532130
Locus: 17p13.3
Gene Diseases
The SLC43A2 SMYD4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|